PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice. (Q51498703)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16672921%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16672921%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16672921%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Park CW

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16672921%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Zhang Y

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16672921%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Zhang X

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16672921%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Chen L

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16672921%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Cha DR

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16672921%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Su D

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16672921%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Hwang MT

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16672921%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Fan X

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16672921%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Davis L

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16672921%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Striker G

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16672921%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Zheng F

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16672921%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Breyer M

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16672921%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Guan Y

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16672921%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

English

0 references

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16672921%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16672921%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16672921%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

1511-1517

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16672921%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16672921%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.ki.5000209

20 January 2020

exact match

0 references

cites work

Insulin resistance: From predisposing factor to therapeutic target in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Insulin resistance and non-insulin-dependent diabetes mellitus: cellular and molecular mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Insulin and insulin resistance: impact on blood pressure and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Peroxisome proliferator-activated receptor gamma: implications for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Effects of comicronised fenofibrate on lipid and insulin sensitivity in patients with polymetabolic syndrome X.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Mechanisms of fatty acid-induced inhibition of glucose uptake

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Peroxisome Proliferator-Activated Receptors and the Control of Inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Diabetic kidney disease in thedb/dbmouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Adipogenesis and obesity: rounding out the big picture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

PPAR gamma and the control of adipogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Differential influences of peroxisome proliferator-activated receptors gamma and -alpha on food intake and energy homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Effects of ciprofibrate and fenofibrate on liver lipids and lipoprotein synthesis in normo- and hyperlipidemic rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Peroxisome proliferator activated receptor-alpha expression in human liver.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

PPAR agonists amplify iNOS expression while inhibiting NF-kappaB: implications for mesangial cell activation by cytokines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Reduction of insulin and triglycerides delays glomerulosclerosis in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Utility of endogenous creatinine clearance as a measure of renal function in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Resistance to glomerulosclerosis in B6 mice disappears after menopause

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Renal injury in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021

Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000209

7 January 2021